Overview

Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid

Status:
Terminated
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the effect of the treatment with the GLP-1 Analogon Liraglutide on the lipid metabolism an inflammation in adipose tissue.
Phase:
Phase 3
Details
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Treatments:
Glucagon
Glucagon-Like Peptide 1
Liraglutide